Stephan Stilgenbauer

73.8k citations

517 papers · 23.5k indexed · 5 hit papers · h-index 75

Impact in

Genetics top 0.01%
- Chronic Lymphocytic Leukemia Research
- Genomic variations and chromosomal abnormalities
Pathology and Forensic Medicine top 0.01%
- Lymphoma Diagnosis and Treatment

Papers in

Genetics 428
- Chronic Lymphocytic Leukemia Research 427
Pathology and Forensic Medicine 264
- Lymphoma Diagnosis and Treatment 260

Co-authors: Hartmut Döhner Peter Lichter Axel Benner Martin Bentz Lars Bullinger Alexander Kröber Thorsten Zenz Michael Hallek
Journals: Blood (200 papers)Leukemia (38 papers)Journal of Clinical Oncology (37 papers)Haematologica (19 papers)International Journal of Cancer (13 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Stephan Stilgenbauer

492 papers receiving 23.0k citations

Hit Papers

5 papers align trajectories log scale

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL 2018 · 971 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Blood
2002 Blood
2000 New England Journal of Medicine
1997 Genes Chromosomes and Cancer
1995 Blood

Peers

Countries citing papers authored by Stephan Stilgenbauer

Since Specialization

Citations

This map shows the geographic impact of Stephan Stilgenbauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Stilgenbauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Stilgenbauer more than expected).

Fields of papers citing papers by Stephan Stilgenbauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Stilgenbauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Stilgenbauer. The network helps show where Stephan Stilgenbauer may publish in the future.

Co-authors

The 25 scholars most cited alongside Stephan Stilgenbauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephan Stilgenbauer Line = papers co-authored together Stephan Stilgenbauer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The significance of PAX5 in Merkel cell carcinoma The Journal of Pathology ·Emil Chteinberg, Julia Kolarova, J. Vogt, Amanda Macamo, Felix Bormann, Helene Kretzmer, Ernst‐Jan M. Speel, Joost van den Oord, Christof Schneider, Stephan Stilgenbauer, Jürgen C. Becker, Véronique Winnepenninckx, Erik A.L. Biessen, Martin Zenke, Anna Kordelia Kurz, Reiner Siebert, Axel zur Hausen	2025	0
2	Venetoclax Initiation in Chronic Lymphocytic Leukemia: International Insights and Innovative Approaches for Optimal Patient Care Cancers ·Mary Ann Anderson, Renata Walewska, Fidelma Hackett, Arnon P. Kater, Josie Montegaard, Susan O’Brien, John F. Seymour, Matthew D. Smith, Stephan Stilgenbauer, Ashley Whitechurch, Jennifer R. Brown	2024	2
3	Comparison of R‐CHOP‐14 and R‐mini‐CHOP in older adults with diffuse large B‐cell lymphoma—A retrospective multicenter cohort study European Journal Of Haematology ·Zelal Guel Dilbaz, Sophy Denker, Carla Ankermann, Joerg‐Thomas Bittenbring, Dominic Kaddu‐Mulindwa, A. Kunte, S Hünecke, Viola Poeschel, Stephan Stilgenbauer, Lorenz Thurner, Il‐Kang Na, Moritz Bewarder, Konstantinos Christofyllakis	2024	1
4	Preliminary Efficacy and Safety of the Bruton Tyrosine Kinase Degrader BGB-16673 in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Results from the Phase 1 CaDAnCe-101 Study Blood ·Meghan C. Thompson, Ricardo Parrondo, Anna Maria Frustaci, John N. Allan, Paolo Ghia, Irina Mocanu, Constantine S. Tam, Judith Trotman, Inhye E. Ahn, Stephan Stilgenbauer, Lydia Scarfò, Xiangmei Chen, Kunthel By, Shannon Fabre, Daniel O. Persky, Amit Agarwal, John F. Seymour	2024	14
5	Impairment of α-tubulin and F-actin interactions of GJB3 induces aneuploidy in urothelial cells and promotes bladder cancer cell invasion Cellular & Molecular Biology Letters ·Junnan Liu, Xue Wang, Wencheng Jiang, Anca Azoitei, Tim Eiseler, Markus Eckstein, Arndt Hartmann, Stephan Stilgenbauer, Mohamed Elati, Meike Hohwieler, Alexander Kleger, Axel John, Felix Wezel, Friedemann Zengerling, Christian Bolenz, Çagatay Güneş	2024	1
6	Genetic markers and ibrutinib vs placebo treatment in early stage chronic lymphocytic leukemia -results from the GCLLSG CLL12 trial Blood ·Armin Riecke, Eugen Tausch, Deyan Y. Yosifov, Christof Schneider, Sandra Robrecht, Adam Giza, Lothar Müller, Ursula Vehling‐Kaiser, Michael J. Eckart, Werner Freier, Björn Schöttker, Tobias Gaska, Marcel Reiser, Anna‐Maria Fink, Barbara Eichhorst, Kirsten Fischer, Michael Hallek, Petra Langerbeins, Stephan Stilgenbauer	2023	0
7	Circulating Tumor DNA–Based MRD Assessment in Patients with CLL Treated with Obinutuzumab, Acalabrutinib, and Venetoclax Clinical Cancer Research ·Moritz Fürstenau, Jonathan M. Weiss, Adam Giza, Fabian Franzen, Sandra Robrecht, Anna‐Maria Fink, Kirsten Fischer, Christof Schneider, Eugen Tausch, Stephan Stilgenbauer, Matthias Ritgen, Anke Schilhabel, Monika Brüggemann, Barbara Eichhorst, Michael Hallek, Paula Cramer	2022	17
8	Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape Nature Communications ·Maurizio Mangolini, Alba Maiqués-Díaz, Stella Charalampopoulou, Elena Hartmann, Johannes Bloehdorn, A. P. Moore, Giorgia Giachetti, Junyan Lu, Valar Nila Roamio Franklin, Chandra Sekkar Reddy Chilamakuri, Ilias Moutsopoulos, Andreas Rosenwald, Stephan Stilgenbauer, Thorsten Zenz, Irina Mohorianu, Clive S. D’Santos, Silvia Deaglio, Daniel J. Hodson, José I. Martı́n-Subero, Ingo Ringshausen	2022	19
9	Discovery of Candidate DNA Methylation Cancer Driver Genes Cancer Discovery ·Heng Pan, Loïc Renaud, Ronan Chaligné, Johannes Bloehdorn, Eugen Tausch, Daniel Mertens, Anna Maria Fink, Kirsten Fischer, Chao Zhang, Doron Betel, Andreas Gnirke, Marcin Imieliński, Jérôme Moreaux, Michael Hallek, Alexander Meissner, Stephan Stilgenbauer, Catherine J. Wu, Olivier Elemento, Dan A. Landau	2021	53
10	EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4+ T cells in chronic lymphocytic leukemia Leukemia ·Philipp M. Roessner, Laura Llaó Cid, Ekaterina Lupar, Tobias Roider, Marie Bordas, Christoph Schifflers, Lavinia Arseni, Ann‐Christin Gaupel, Fabian Kilpert, Marit Krötschel, Sebastian J. Arnold, Leopold Sellner, Dolors Colomer, Stephan Stilgenbauer, Sascha Dietrich, Peter Lichter, Ana Ízcue, Martina Seiffert	2021	30
11	EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia Leukemia ·Laura Llaó Cid, Philipp M. Roessner, Vicente Chapaprieta, Selcen Öztürk, Tobias Roider, Marie Bordas, Ana Ízcue, Dolors Colomer, Sascha Dietrich, Stephan Stilgenbauer, Bola S. Hanna, José I. Martı́n-Subero, Martina Seiffert	2021	29
12	FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials European Journal of Nuclear Medicine and Molecular Imaging ·Dominic Kaddu‐Mulindwa, Bettina Altmann, Gerhard Held, Stephanie Angel, Stephan Stilgenbauer, Lorenz Thurner, Moritz Bewarder, Maren Schwier, Michael Pfreundschuh, Markus Löffler, Karin Menhart, Jirka Grosse, Marita Ziepert, Ken Herrmann, Ulrich Dührsen, Andreas Hüttmann, Francesco Barbato, Viola Poeschel, D. Hellwig	2021	20
13	Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study Clinical Cancer Research ·Matthew S. Davids, Bryone J. Kuss, Peter Hillmen, Marco Montillo, Carol Moreno, James Essell, Nicole Lamanna, Zsolt Nagy, Constantine S. Tam, Stephan Stilgenbauer, Paolo Ghia, Julio Delgado, Stephanie Lustgarten, David T. Weaver, Hagop Youssoufian, Ulrich Jäger	2020	33
14	Lamin B1 regulates somatic mutations and progression of B-cell malignancies Leukemia ·Tetyana Klymenko, Johannes Bloehdorn, Jasmin Bahlo, Sandra Robrecht, Gulnara Akylzhanova, Kerry L. Cox, Sven Estenfelder, Jun Wang, Jennifer Edelmann, Jonathan C. Strefford, Tomasz K. Wojdacz, Kirsten Fischer, Michael Hallek, Stephan Stilgenbauer, Mark S. Cragg, John G. Gribben, Andrejs Braun	2017	22
15	Evolution of DNA Methylation Is Linked to Genetic Aberrations in Chronic Lymphocytic Leukemia Cancer Discovery ·Christopher C. Oakes, Rainer Claus, Lei Gu, Yassen Assenov, Jennifer Hüllein, Manuela Zucknick, Matthias Bieg, David Brocks, Olga Bogatyrova, Christopher R. Schmidt, Laura Z. Rassenti, Thomas J. Kipps, Daniel Mertens, Peter Lichter, Hartmut Döhner, Stephan Stilgenbauer, John C. Byrd, Thorsten Zenz, Christoph Plass	2013	110
16	Cellular origin and pathophysiology of chronic lymphocytic leukemia The Journal of Experimental Medicine ·Marc Seifert, Ludger Sellmann, Johannes Bloehdorn, Frederik Wein, Stephan Stilgenbauer, Jan Dürig, Ralf Küppers	2012	184
17	miRNA-130a Targets ATG2B and DICER1 to Inhibit Autophagy and Trigger Killing of Chronic Lymphocytic Leukemia Cells Cancer Research ·Valentina Kovaleva, Rodrígo Mora, Yoon Jung Park, Christoph Plass, Abhilash I. Chiramel, Ralf Bartenschlager, Hartmut Döhner, Stephan Stilgenbauer, Armin Pscherer, Peter Lichter, Martina Seiffert	2012	161
18	Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia Blood ·William G. Wierda, Thomas J. Kipps, Jan Dürig, Laimonas Griškevičius, Stephan Stilgenbauer, Jiřı́ Mayer, Lukáš Smolej, Georg Heß, Rasa Griniūtė, Francisco J. Hernandez‐Ilizaliturri, Swaminathan P. Iyer, M Gorczyca, Chai-Ni Chang, Geoffrey Chan, Ira Gupta, Tina Nielsen, Charlotte Russell	2011	86
19	A Novel Paradigm to Trigger Apoptosis in Chronic Lymphocytic Leukemia Cancer Research ·Sandra Loeder, Thorsten Zenz, Andrea Schnaiter, Daniel Mertens, Dirk Winkler, Hartmut Döhner, Klaus‐Michael Debatin, Stephan Stilgenbauer, Simone Fulda	2009	45
20	First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia Blood ·Barbara Eichhorst, Raymonde Busch, Stephan Stilgenbauer, Martina Stauch, Manuela A. Bergmann, Matthias Ritgen, N Kranzhöfer, Robert Rohrberg, Ulrike Söling, Oswald Burkhard, Anne Westermann, Valentin Goede, Carmen D. Schweighofer, Kirsten Fischer, Anna‐Maria Fink, Clemens‐Martin Wendtner, Günter Brittinger, Hartmut Döhner, Bertold Emmerich, Michael Hallek, (unknown)	2009	238

About Stephan Stilgenbauer

Stephan Stilgenbauer is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Hematology and Oncology, having authored 517 papers that have together received 23.5k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (427 papers), Lymphoma Diagnosis and Treatment (260 papers), Immunodeficiency and Autoimmune Disorders (155 papers), Acute Lymphoblastic Leukemia research (58 papers), Advanced Breast Cancer Therapies (54 papers), Chronic Myeloid Leukemia Treatments (48 papers), Cancer-related Molecular Pathways (33 papers) and Glycosylation and Glycoproteins Research (30 papers). The work is most often cited by research in Genetics (16.2k citations), Pathology and Forensic Medicine (12.9k citations), Immunology (7.8k citations), Hematology (3.5k citations) and Oncology (4.8k citations). Stephan Stilgenbauer has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Hartmut Döhner, Peter Lichter, Axel Benner, Martin Bentz, Lars Bullinger, Alexander Kröber, Thorsten Zenz, Michael Hallek, Konstanze Döhner and Elke Leupolt. Their work appears in journals such as Blood, Leukemia, Journal of Clinical Oncology, Haematologica and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact